Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1991
03/08/1991CA2024728A1 Use of antiprogestomimetic compositions
03/08/1991CA2024724A1 Fatty acid therapy
03/08/1991CA2024697A1 Protein having anticoagulant properties
03/08/1991CA2024630A1 Paf-antagonists for the preparation of a pharmaceutical composition suitable for treating heart diseases caused by reduced stimulation of .beta.-receptors
03/08/1991CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
03/07/1991WO1991003099A1 Compressed powder medicaments
03/07/1991WO1991002736A1 Macrocyclic compounds
03/07/1991WO1991002735A1 Chemical compounds based on a netropsin or distamycin molecule coupled with an intercalating agent, method for preparing said compounds and pharmaceutical compositions containing same
03/07/1991WO1991002721A1 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds
03/07/1991WO1991002718A1 Novel amino acid derivatives, method for preparing them, and their therapeutical applications
03/07/1991WO1991002543A1 Stabilized vaccine compositions
03/07/1991WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof
03/07/1991WO1991002535A1 Cancer prevention composition and method
03/07/1991WO1991002533A1 Topical compositions containing lycd and other topically active medicinal ingredients
03/07/1991WO1991002531A1 Method for the modulation of haemopoiesis in a mammal
03/07/1991WO1991002530A1 Accelerator for periodontal tissue regeneration
03/07/1991WO1991002529A2 Product and method for killing abnormal vertebrate cells
03/07/1991WO1991002527A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
03/07/1991WO1991002526A1 Azabicyclo quinolone carboxylic acids
03/07/1991WO1991002523A1 Glutamatergic amino acid agonists and antagonists
03/07/1991WO1991002519A1 Method for increasing the pharmaceutical effect of inositol phosphate and a composition with improved pharmaceutical effect
03/07/1991WO1991002515A1 Anti-inflammatory substances for cosmetic preparation
03/07/1991WO1991002514A1 Anti-inflammatory active substances for cosmetic compositions
03/07/1991WO1991002512A1 Buccal composition containing s(+) flurbiprofen or ketoprofen
03/07/1991WO1991002497A1 Topical nifedipine for cutaneous, ocular, mucosal hypersensitivity, inflammatory and hyperproliferative conditions
03/07/1991WO1991001123A3 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d¿4?
03/07/1991DE4019062A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon
03/07/1991DE3929184A1 Oral dosage forms for angina treatment - contg. iso:sorbide di:nitrate
03/07/1991DE3928707A1 Entzuendungshemmende wirkstoffe fuer kosmetische praeparate Anti-inflammatory ingredients for cosmetic preparations
03/07/1991DE3928470A1 Compsn. for treating flaking of skin - contains ethanol, 2-propanol, 1-propanol and mecetronium ethyl sulphate
03/07/1991CA2065375A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
03/07/1991CA2065023A1 Stabilized vaccine compositions
03/07/1991CA2064592A1 Amino acid derivatives, their preparation process and their therapeutic applications
03/07/1991CA2024576A1 Hmg-coa reductase-inhibiting substituted amino-pyridines
03/07/1991CA2024523A1 Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents
03/07/1991CA2024428A1 Agent for treating urinary obstruction
03/06/1991WO1991003271A1 Apparatus for administering medicaments to mucosal tissue
03/06/1991WO1991003237A1 Compositions and methods of manufacture of oral dissolvable medicaments
03/06/1991WO1991003236A1 Transmucosal dosage form
03/06/1991EP0415902A1 Oxy- or thio-substituted fatty acid analogs for use in the treatment of retroviral infections
03/06/1991EP0415889A2 Anthelmintic agent
03/06/1991EP0415886A2 Aza compounds
03/06/1991EP0415850A1 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophene-acid, process for their preparation and pharmaceutical compositions containing them
03/06/1991EP0415776A2 Indolobenzoquinoline derivatives, their preparation and their use as anti-arrhythmic drugs
03/06/1991EP0415766A2 Use of retinoids for reversing glucocorticoid-induced skin atrophy
03/06/1991EP0415693A1 Composition and method for selective enhancement of opiate activity and reduction of opiate tolerance and dependence
03/06/1991EP0415634A2 Benzazabicyclic carbamates as cholinesterase inhibitors
03/06/1991EP0415623A2 Toremifene or demethyltoremifene as hydroxytoremifene for the reversal of multidrug restistance of cancer cells against cytotoxic drugs
03/06/1991EP0415613A2 Use of sertraline for the treatment of premature ejaculation
03/06/1991EP0415612A2 Use of sertraline for the treatment of chemical dependencies
03/06/1991EP0415605A1 Thiazolidinedione derivatives
03/06/1991EP0415566A1 Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them
03/06/1991EP0415564A2 Use of prostanoic acid derivaties for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine
03/06/1991EP0415524A1 Process for the production of 2-halomethyl-6-methoxy naphthalene
03/06/1991EP0415522A1 Process for reducing the crystal size of ondansetron hydrochloride dihydrate
03/06/1991EP0415510A2 L-glutamic acid derivatives
03/06/1991EP0415488A2 7-Substituted HMG-COA reductase inhibitors
03/06/1991EP0415487A2 Beta-lactams as anticholesterolemic agents
03/06/1991EP0415458A2 Use of retinoids for preventing and reducing the size of striae distensae lesions
03/06/1991EP0415456A2 Xanthine compounds
03/06/1991EP0415453A2 Epipodophyllotoxin altroside derivatives
03/06/1991EP0415430A1 Stable solutions of mitomycin C
03/06/1991EP0415413A1 Acat inhibitors
03/06/1991EP0415384A2 Heterogeneous synthesis of azepinones from esters
03/06/1991EP0415304A2 Dipyrido[3,2-b:2',3'-e][1,4]oxazepin (and thiazepin)-6(5H)-ones and their use in the prevention or treatment of aids
03/06/1991EP0415303A2 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection
03/06/1991EP0415263A2 Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives
03/06/1991EP0415198A2 Ketophosphamidyl glycosides, process for their preparation and their use as pharmaceutical agents
03/06/1991EP0415126A1 Anti-dental plaque agents
03/06/1991EP0415103A1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
03/06/1991EP0415102A1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments
03/06/1991EP0415065A1 Chroman derivatives
03/06/1991EP0415030A2 1-Substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[1,5-A]pyrimidine-8-carbonitriles
03/06/1991EP0415018A1 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations
03/06/1991EP0414952A1 Dithiolane derivatives
03/06/1991EP0414931A1 Hypotensive agent
03/06/1991EP0414903A1 New thioproline derivative
03/06/1991EP0414895A1 OROTATE OF $g(a)-AMINO-$g(b)-PHENYL-BUTYRIC ACID
03/06/1991EP0414894A1 Derivatives of trichlorophosphasohydrocarbons and insecticidal bactericidal, fungicidal, viricidal and ovocidal preparations based on them
03/06/1991EP0414815A1 Blood substitute
03/06/1991EP0414806A1 High ratio active agent:lipid complex.
03/06/1991EP0190356B1 Novel amidine compounds
03/06/1991CN1049669A Antibacterial antiplaque oral composition contaning copolymer of styrene phosphonic acid
03/06/1991CN1049668A Process for preparing sequence of antidirection direction, antimessenger rna oligonuclectides of alpha tnf
03/06/1991CN1049665A Carboxylamide derivatives
03/06/1991CN1049664A Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo (1,5-a)-1,3,5-triazines
03/06/1991CN1049663A Pyrroloquinoline compounds
03/06/1991CN1049662A Coumarin derivatives, their prepn. and their use in treatment of cerebrovascular disorders
03/06/1991CN1049660A Aminoketone derivatives and use thereof
03/06/1991CN1049658A (quinolin-2-yl-methoxy) phenylacetic acid derivatives containing cyclic substituents
03/06/1991CN1049657A Disubstituted(quinolin-2-yl-methoxy) phenylacetic acid derivatives
03/06/1991CN1049656A Substitutes n-(quinolin-2-yl-methoxy) benzyl-sulphonyl-ureas
03/06/1991CN1049608A Method of teeth and their supporting tissue
03/06/1991CA2024698A1 Peptidyl diflurodiol renin inhibitors
03/06/1991CA2024587A1 Drug delivery compositions based on biological cells or components thereof and methods
03/06/1991CA2024581A1 Substituted n-benzylpiperidine amides
03/06/1991CA2024580A1 Tricyclic quinolizine amides
03/06/1991CA2024579A1 N-benzyltropaneamides
03/06/1991CA2024546A1 Process for the preparation of optically active aryl-2 propionic acids
03/05/1991US4997961 Forming thiol ethers from 1,8-dihydroxyanthrones for treatment of psoriasis and formation of vehicles for topical application
1 ... 7363 7364 7365 7366 7367 7368 7369 7370 7371 7372 7373 7374 7375 7376 7377 7378 7379 7380 7381 7382 7383 ... 7860